U.S. FDA inspection at Lupin's Tarapur manufacturing facility

The U.S. FDA has concluded an inspection at Lupin Ltd's Tarapur manufacturing facility.

The inspection was carried out between March 22, 2022 and April 4, 2022.

The inspection closed with four observations. We are confident of addressing the observations to the U.S. FDA's satisfaction. We are committed to adherence and full compliance with CGMP regulations and uphold the highest quality standar;ds across our manufacturing sites.

Shares of Lupin Limited was last trading in BSE at Rs. 790.05 as compared to the previous close of Rs. 765.25. The total number of shares traded during the day was 85695 in over 3279 trades.

The stock hit an intraday high of Rs. 792.35 and intraday low of 762.70. The net turnover during the day was Rs. 66434592.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 USFDA Inspection Tarapur ManufacturingFacility FourObservations